Evidence map›Paper›PMID 34262989›Full record

ArticleOpen forum infectious diseases2021

Factors and Outcomes Related to the Use of Guideline-Recommended Antibiotics in Patients With Neutropenic Fever at the Uganda Cancer Institute.

Elizabeth A Gulleen, Scott V Adams, Bickey H Chang, Lauren Falk, Riley Hazard, Johnblack Kabukye, Jackie Scala, Catherine Liu, Warren Phipps, Omoding Abrahams and 1 more

Abstract read
In one paragraph

Article in Open forum infectious diseases, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Elizabeth A GulleenVaccine and Infectious Diseases Divison, Fred Hutchinson Cancer Research Center, Seattle, Washington, USA.ORCID https://orcid.org/0000-0003-0035-5015
Scott V AdamsVaccine and Infectious Diseases Divison, Fred Hutchinson Cancer Research Center, Seattle, Washington, USA.ORCID https://orcid.org/0000-0002-8411-8051
Bickey H ChangDepartment of Internal Medicine, University of Minnesota, Minneapolis, Minnesota, USA.
Lauren FalkDepartment of Obstetrics and Gynecology, Rush University Medical Center, Chicago, Illinois, USA.
Riley HazardSchool of Population and Global Health, University of Melbourne, Melbourne, Australia.ORCID https://orcid.org/0000-0003-3774-2705
Johnblack KabukyeUganda Cancer Institute, Kampala, Uganda.ORCID https://orcid.org/0000-0002-7864-1858
Jackie ScalaDepartment of Internal Medicine, University of Texas at San Antonio, San Antonio, Texas, USA.ORCID https://orcid.org/0000-0002-6370-0771
Catherine LiuVaccine and Infectious Diseases Divison, Fred Hutchinson Cancer Research Center, Seattle, Washington, USA.ORCID https://orcid.org/0000-0002-7532-4822
Warren PhippsVaccine and Infectious Diseases Divison, Fred Hutchinson Cancer Research Center, Seattle, Washington, USA.ORCID https://orcid.org/0000-0003-3564-8571
Omoding AbrahamsUganda Cancer Institute, Kampala, Uganda.ORCID https://orcid.org/0000-0002-5995-1471
Christopher C MooreDivision of Infectious Diseases and International Health, Department of Medicine, University of Virginia, Charlottesville, Virginia, USA.

Funding

Expanding independent research capacity in HIV-associated malignancies in UgandaD43TW009759 · FIC · FRED HUTCHINSON CANCER RESEARCH CENTER · PI OREM, JACKSON, PHIPPS, WARREN · 2014 to 2023
$3.0M
FIC NIH HHS D43 TW009759
6 · The paper itself

Abstract

backgroundNeutropenic fever (NF) is associated with significant morbidity and mortality for patients receiving cancer treatment in sub-Saharan Africa (sSA). However, the antibiotic management of NF in sub-Saharan Africa has not been well described. We evaluated the timing and selection of antibiotics for patients with NF at the Uganda Cancer Institute (UCI).

methodsWe conducted a retrospective chart review of adults with acute leukemia admitted to UCI from 1 January 2016 to 31 May 2017, who developed NF. For each NF event, we evaluated the association of clinical presentation and demographics with antibiotic selection as well as time to both initial and guideline-recommended antibiotics. We also evaluated the association between ordered antibiotics and the in-hospital case fatality ratio (CFR).

resultsForty-nine NF events occurred among 39 patients. The time to initial antibiotic order was <1 day. Guideline-recommended antibiotics were ordered for 37 (75%) NF events. The median time to guideline-recommended antibiotics was 3 days. Fever at admission, a documented physical examination, and abdominal abnormalities were associated with a shorter time to initial and guideline-recommended antibiotics. The in-hospital CFR was 43%. There was no difference in in-hospital mortality when guideline-recommended antibiotics were ordered as compared to when non-guideline or no antibiotics were ordered (hazard ratio, 0.51 [95% confidence interval {CI}, .10-2.64] and 0.78 [95% CI, .20-2.96], respectively).

conclusionsPatients with acute leukemia and NF had delayed initiation of guideline-recommended antibiotics and a high CFR. Prospective studies are needed to determine optimal NF management in sub-Saharan Africa, including choice of antibiotics and timing of antibiotic initiation.

Indexed as

antimicrobial stewardshipguideline adherencehematologic malignancyneutropenic feversub-Saharan Africa

Identifiers

PMID34262989
PMCPMC8275883

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.